FFAs are involved in a diverse range of functions within hepatic cells, including esterifi cation into triacylglycerols (TAGs); oxidation to fuel mitochondrial metabolism, synthesis, and remodeling of phospholipids (PLs); and conversion to signaling molecules such as prostaglandins or leukotrienes. The effects of elevated FFAs have been previously studied in cultured hepatic cell lines as a model for recapitulating the lipotoxicity that has been observed in obese type 2 diabetes and nonalcoholic fatty liver disease (NAFLD) ( 1-5 ). In these disease states, ectopic accumulation of FFAs in nonadipose tissues such as liver, pancreas, and skeletal muscle can interfere with normal cellular function and induce apoptotic cell death. These lipotoxic effects have shown dependence on FA chain length and saturation. Exposure to long-chain saturated FAs (SFAs), such as palmitate (PA) or stearate, leads to lipoapoptosis in many cell types including hepatocytes ( 2, 6, 7 ). In contrast, MUFAs, such as oleate (OA) , are not acutely cytotoxic to hepatic cells and have been shown to exert a protective effect when combined with toxic loads of SFAs ( 8-10 ).The mechanism by which metabolism of specifi c lipid species results in apoptosis has not been fully elucidated.